Related Experiment Video
Updated: May 1, 2026

12:10
Semi-automated Optical Heartbeat Analysis of Small Hearts
Published on: September 16, 2009
11.7K
Lay Stakeholders in Science and Research Initiative: A Science Advisory From the American Heart Association.
Circulation
|June 28, 2021
Summary
The American Heart Association (AHA) now includes patients and advocates in research decisions. This collaboration enhances cardiovascular research funding and direction, improving health outcomes.
Area of Science:
- Cardiovascular Research
- Health Policy
- Patient Advocacy
Background:
- The American Heart Association (AHA) is a leading non-profit funder of cardiovascular and cerebrovascular disease research.
- For seven decades, the AHA has supported independent scientific research to reduce disease-related death and disability.
- In 2014, the AHA initiated a pilot program to involve lay stakeholders in its research operations.
Purpose of the Study:
- To assess the impact of including lay stakeholders (patients, caregivers, advocates) in the AHA's research and science operations.
- To determine if lay perspectives improve decisions regarding research funding, direction, and scientific guidelines.
- To evaluate the framework, recruitment, training, and integration of lay stakeholders.
Main Methods:
- Developed a framework defining lay stakeholders and outlining recruitment, training, and integration policies.
- Established metrics for evaluating the initiative's effectiveness over time.
- Implemented creative engagement strategies to foster collaboration between lay volunteers and scientists.
Main Results:
- Program assessments have been consistently positive, indicating successful integration and collaboration.
- The benefits of lay-scientist collaboration have exceeded the AHA's initial expectations.
- Identified areas for future improvement in lay stakeholder engagement and scientist communication.
Conclusions:
- Lay stakeholder involvement significantly enhances cardiovascular and cerebrovascular research.
- The AHA will continue to expand and diversify lay volunteer engagement in its scientific endeavors.
- Strengthening lay-scientist collaboration is crucial for advancing research, improving public health communication, and maintaining donor trust.
More Related Videos
Related Concept Videos
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
1.9K
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
1.9K
Ischemic Heart Disease: Overview
3.8K
Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
3.8K
Coronary Artery Disease IV: Preventive Measures
890
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
890
Acute Coronary Syndrome IV: Interprofessional Care
522
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
522
Atherosclerosis III: Management
741
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
741
Atherosclerosis IV: Nursing Management
611
Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
611

